Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10 Lymphoma, T-Cell, Cutaneous 10 Lymphoma, Non-Hodgkin 10 Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Acute 9 Leukemia, Hairy Cell 9 Hodgkin Disease 9 Burkitt Lymphoma 9 Sezary Syndrome 8 Mycosis Fungoides 8 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 7 Leukemia, Myeloid, Accelerated Phase 7 Blast Crisis 7 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6 Multiple Myeloma 6 Melanoma 6 Leukemia, Myelomonocytic, Chronic 6 Breast Neoplasms 6 Waldenstrom Macroglobulinemia 5 Primary Myelofibrosis 5 Myeloproliferative Disorders 5 Lymphoma, Large-Cell, Anaplastic 5 Lymphoma, Extranodal NK-T-Cell 5 Leukemia, Prolymphocytic 5

Interventions

HhAntag691 21 Imiquimod 12 Biopsy 9 Aminolevulinic Acid 9 Photochemotherapy 8 sonidegib 7 1-phenyl-3,3-dimethyltriazene 7 methyl 5-aminolevulinate 6 cemiplimab 5 Tomography, Optical Coherence 5 Surgical Procedures, Operative 5 Nivolumab 5 pembrolizumab 4 Radiotherapy 4 Mohs Surgery 4 Itraconazole 4 Curettage 4 Standard of Care 3 Specimen Handling 3 Niacinamide 3 Microscopy, Confocal 3 IPI-926 3 tazarotene 2 talimogene laherparepvec 2 daromun 2 Watchful Waiting 2 Sirolimus 2 Microarray Analysis 2 Magnetic Resonance Spectroscopy 2 Laser Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03610022 2022-08-18

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡